The current study suggests that the essential components of UFMylation (such as UFM1, UFBP1, and CDK5RAP3) are underexpressed in GC tissues, and this downregulation is closely linked with increased cell proliferation, invasion, drug resistance, and poor patient prognosis [20,52,58]. The gene discussed is UFM1; the disease is gastric cancer.